Last updated on September 2017

Efficacy and Safety of Cinacalcet in Ca P and iPTH Levels in Patients With Mild Moderate and Severe SHPT


Brief description of study

1. To evaluate achievement ratio of iPTH,Calcium and phosphorus after taking Cinacalcet HCL in hemodialysis subjects with mild, moderate and severe SHPT; 2. To explore the impact of Cinacalcet HCL using on the combined use of drugs; 3. To explore the difference of patients who continued or discontinued Cinacalcet HCL in real-world period from 33rd to 52nd week.

Clinical Study Identifier: NCT03123406

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Zhihong Liu

Nanjing Jinling Hospital
Nanjing, China
  Connect »